Skip to main content
. 2020 Mar 2;61(1):16–21. doi: 10.4103/nmj.NMJ_128_19

Table 4.

Duration of the nasal mass at presentation

Duration (years) Nonneoplastic Benign Malignant Total (%)
1–3 14 8 7 29 (76.3)
4–6 2 0 0 2 (5.3)
7–9 0 1 0 1 (2.6)
10–12 0 6 0 6 (15.8)
Total (%) 16 (62.1) 15 (39.5) 7 (18.4) 38 (100)